biOasis Announces Non-Brokered Private Placement
08 août 2014 21h09 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 8, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF)(the "Company") announces a non-brokered private placement of up to...
biOasis Releases Quantitative Results: siRNA-Transcendpep Reduces Target Gene Expression in the Brain
25 juil. 2014 09h30 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 25, 2014) - BIOASIS TECHNOLOGIES INC. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Appoints New Chief Financial Officer and Corporate Secretary
20 juin 2014 19h30 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 20, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Enters Investor Relations Agreement with Gale Capital Corporation
16 juin 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 16, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI) (OTCQX:BIOAF) (the "Company") is pleased to announce that is has retained Gale...
biOasis Secures DTC Eligibility
08 mai 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 8, 2014) - biOasis Technologies Inc. (OTCQX:BIOAF) (TSX VENTURE:BTI), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Delivers siRNA to the Brain Using its Transcend Peptide Vector
06 mai 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 6, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Discovers the Keys to Transcend to Advance Its Program for the Delivery of Therapeutics Across the Blood-Brain Barrier
24 avr. 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 24, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Presents Results From It's BT2111 Program at International Cancer Research Conference
03 avr. 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 3, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Receives Patent Allowances for Lysosomal Storage Disease Therapeutic in Europe and Canada
27 mars 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 27, 2014) - biOasis Technologies Inc. (TSX VENTURE:BTI)(OTCQX:BIOAF), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Enters Into a License Agreement With Medimmune for Second Generation Versions of biOasis's Transcend
17 mars 2014 09h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 17, 2014) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), a pioneering biopharmaceutical company focused on overcoming the...